Bristol-Myers Squibb Company (BMY)
Last Price$59.810.5%
Market Cap$97.6B
Financial ratios score
8/10
Revenue growth
(2.5%)
Industry median: 6.1%
Net income growth
26.8%
Industry median: (29.0%)
Free cash flow margin
28.1%
Industry median: (222.2%)
Net Debt / EBITDA
1.5x
Industry median: 1.0x
ROIC
23.0%
Industry median: (39.5%)
BMY Growth
Crunching data... Almost there!
BMY Profitability
Crunching data... Almost there!
BMY Bankruptcy probability
Crunching data... Almost there!
BMY Returns on capital
Crunching data... Almost there!
Discover more BMY fundamentals
Stock picking tips.
Ultimate guide 2024
Discover the secrets to successful stock picking in 2024!
We asked 1,000 top investors for their insights on the best stocks, investment strategies, and market trends.
FAQ
Is Bristol-Myers Squibb Company (BMY) going bankrupt?
As of today, Bristol-Myers Squibb Company has a low bankruptcy probability due to healthy solvency ratios.
What is Bristol-Myers Squibb Company (BMY) ROIC?
As of today, Bristol-Myers Squibb Company ROIC is 23.0%, based on the financial report for Dec 31, 2023 (Q4 2023).
Is Bristol-Myers Squibb Company (BMY) ROIC good?
As of today, Bristol-Myers Squibb Company ROIC is 23.0%, which is higher than 15%, that is considered a good ROIC ratio.